A novel BCAT1 inhibitor bufalin sensitizes pancreatic cancer cells to chemotherapy.

ABSTRACT:

SUBMITTER: Zhang W 

PROVIDER: S-EPMC11803225 | biostudies-literature | 2025 May

REPOSITORIES: biostudies-literature